All Insights
Showing 1 - 12 of 580
    
                                            
    
Regulatory Outlook
                                        
                Digital regulation | UK Regulatory Outlook October 2025
  UK: 'Cyberflashing' to be made priority offence | Ofcom consults on data preservation notices | Media Act 2024 (Commencement No.3)
                                    
                                            
    
Regulatory Outlook
                                        
                Data law | UK Regulatory Outlook October 2025
  UK: ICO consults on new 'charitable purpose soft opt-in' under DUA Act | ICO survey on advice when sharing data
                                    
                                            
    
Regulatory Outlook
                                        
                Cyber security | UK Regulatory Outlook October 2025
  National Cyber Security Centre publishes 2025 annual review | Ministerial letter on cyber security to UK companies | ENISA Threat
                                    
                                            
    
Regulatory Outlook
                                        
                Artificial intelligence | UK Regulatory Outlook October 2025
  UK: Clearview AI faces recognition case: Upper Tribunal rules that Clearview processing falls within GDPR | Government announces new AI
                                    
                                            
    
Data Centres
                                        
                Sustainable data centre development in the EU: added value or legal requirement?
  EU regulations drive sustainable data centre solutions that support digital transformation and environmental objectives
                                    
                                            
    
Digital Regulation
                                        
                EU Digital Fairness Act unpacked: 'horizontal' issues
  Section 9 of the consultation on the legislation addresses five specific measures and broader 'cross-cutting' matters
                                    
                                            
    
Digital Regulation
                                        
                EU Digital Fairness Act unpacked: simplification measures
  What are the Commission’s considerations regarding simplification measures and why and how are these being explored?
                                    
                                            
    
Digital Regulation
                                        
                EU Digital Fairness Act unpacked: digital contracts
  The legal framework to consider is diverse but guidelines have been set while implementation challenges lie ahead
                                    
                                            
    
Intellectual property
                                        
                Getty Images v Stability AI: a landmark trial for generative AI in UK?
  With judgment day in the offing, the issues raised in the case will help craft the UK landscape for AI
                                    
                                            
    
IT and data
                                        
                CJEU clarifies concepts of personal and pseudonymised data: implications for data sharing
  Transparency obligations apply to a transfer of pseudonymised data, even if it is not identifiable as personal data in the
                                    
                                            
    
Life Sciences and Healthcare
                                        
                EU establishes mandatory CE marking for electronic health record systems
  New framework creates regulatory pathway for electronic health systems while harmonising cross-border health data exchange requirements
                                    
                                            
    
Life Sciences and Healthcare
                                        
                Pharmaceutical suppliers to play central role in delivery of NHS 10-year plan
  A focus on clinical trials and weight-loss medication is a significant opportunity for pharmaceutical manufacturers
                                     
                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                